1. Home
  2. OSBC vs NEO Comparison

OSBC vs NEO Comparison

Compare OSBC & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Old Second Bancorp Inc.

OSBC

Old Second Bancorp Inc.

HOLD

Current Price

$19.97

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$8.18

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSBC
NEO
Founded
1981
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2014
2008

Fundamental Metrics

Financial Performance
Metric
OSBC
NEO
Price
$19.97
$8.18
Analyst Decision
Buy
Buy
Analyst Count
5
7
Target Price
$22.70
$11.14
AVG Volume (30 Days)
377.9K
1.6M
Earning Date
04-22-2026
04-28-2026
Dividend Yield
1.41%
N/A
EPS Growth
N/A
N/A
EPS
1.62
N/A
Revenue
N/A
N/A
Revenue This Year
$25.20
$10.63
Revenue Next Year
$3.66
$9.73
P/E Ratio
$12.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.28
$4.72
52 Week High
$22.43
$13.74

Technical Indicators

Market Signals
Indicator
OSBC
NEO
Relative Strength Index (RSI) 39.73 48.84
Support Level $19.20 $7.33
Resistance Level $20.10 $8.84
Average True Range (ATR) 0.56 0.48
MACD -0.17 0.07
Stochastic Oscillator 23.58 55.91

Price Performance

Historical Comparison
OSBC
NEO

About OSBC Old Second Bancorp Inc.

Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: